Correlation between TCF7 and bladder cancer and feasibility of Erlotinib targeting in bladder cancer: Molecular mechanism and expression of TCF7 recombinant protein.

Mo Z, Gai S, Qin X, Meng D, Wu J, Ya W, Sun S, Huang Q

Open source

DOI
10.1016/j.ijbiomac.2025.140438
Published
2025 Apr
Container
International journal of biological macromolecules
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijbiomac.2025.140438,
  title = {Correlation between TCF7 and bladder cancer and feasibility of Erlotinib targeting in bladder cancer: Molecular mechanism and expression of TCF7 recombinant protein.},
  author = {Mo Z and Gai S and Qin X and Meng D and Wu J and Ya W and Sun S and Huang Q},
  year = {2025},
  journal = {International journal of biological macromolecules},
  doi = {10.1016/j.ijbiomac.2025.140438},
  url = {https://doi.org/10.1016/j.ijbiomac.2025.140438}
}

RIS

TY  - JOUR
TI  - Correlation between TCF7 and bladder cancer and feasibility of Erlotinib targeting in bladder cancer: Molecular mechanism and expression of TCF7 recombinant protein.
AU  - Mo Z
AU  - Gai S
AU  - Qin X
AU  - Meng D
AU  - Wu J
AU  - Ya W
AU  - Sun S
AU  - Huang Q
PY  - 2025
JO  - International journal of biological macromolecules
DO  - 10.1016/j.ijbiomac.2025.140438
UR  - https://doi.org/10.1016/j.ijbiomac.2025.140438
ER  - 

APA

Z, M., S, G., X, Q., D, M., J, W., W, Y., S, S., & Q, H. (2025). Correlation between TCF7 and bladder cancer and feasibility of Erlotinib targeting in bladder cancer: Molecular mechanism and expression of TCF7 recombinant protein.. International journal of biological macromolecules. https://doi.org/10.1016/j.ijbiomac.2025.140438

Source records